{"id":756497,"date":"2025-08-12T18:04:02","date_gmt":"2025-08-12T18:04:02","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=756497"},"modified":"2025-08-12T18:04:02","modified_gmt":"2025-08-12T18:04:02","slug":"why-is-the-global-defibrillator-market-accelerating-in-2025-and-what-it-means-for-healthcare-leaders","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/why-is-the-global-defibrillator-market-accelerating-in-2025-and-what-it-means-for-healthcare-leaders_756497.html","title":{"rendered":"Why Is the Global Defibrillator Market Accelerating in 2025 – And What It Means for Healthcare Leaders?"},"content":{"rendered":"
\n
\"Why<\/a><\/div>\n
\n
Major players in the defibrillator market include Medtronic (Ireland), Stryker (US), Koninklijke Philips N.V. (Netherlands), Asahi Kasei Corporation (Japan), Boston Scientific Corporation (US), Abbott (US), MicroPort Scientific Corporation (China), Nihon Kohden Corporation (Japan), Biotronik (Germany), and CU Medical Systems, Inc. (South Korea).<\/div>\n<\/div>\n<\/div>\n
Browse 337 market data Tables and 57 Figures spread through 296 Pages and in-depth TOC on “Defibrillator Market – Global Forecast to 2030” View detailed Table of Content here – https:\/\/www.marketsandmarkets.com\/Market-Reports\/automated-external-defibrillator-market-549.html<\/div>\n

The global defibrillator<\/a> market is undergoing a transformational phase in 2025, backed by robust demand, technological breakthroughs, and strategic public health initiatives. Valued at US$11.99 billion<\/strong> in 2025, the market is forecasted to reach US$16.44 billion<\/strong> by 2030, propelled by a strong 6.5% CAGR<\/strong>. For C-level executives in the medtech, hospital administration, and investment sectors, this market presents a timely and strategic opportunity.<\/p>\n

This blog dissects what’s fueling this growth, why it’s gaining executive-level attention, and how businesses can position themselves for success in the evolving defibrillator ecosystem.<\/p>\n

Download an Illustrative overview<\/strong><\/a><\/p>\n

What Is Driving Growth in the Global Defibrillator Market?<\/strong><\/p>\n

1. Rise in Cardiovascular Disease (CVD)<\/strong> Cardiovascular diseases remain the leading cause of death globally. In the U.S. alone, over 61% of adults<\/strong> are expected to live with some form of CVD by 2050. This alarming trend is mirrored in emerging markets like India and China, where lifestyle-related conditions such as hypertension, obesity, and diabetes are on the rise.<\/p>\n

These conditions increase the risk of sudden cardiac arrest, making defibrillators—especially Implantable Cardioverter Defibrillators (ICDs)—a critical component in cardiac emergency response.<\/p>\n

2. Expansion of Public Access Programs<\/strong> Government initiatives across North America and Europe are driving the installation of Automated External Defibrillators (AEDs)<\/strong> in public spaces, airports, malls, and schools. Simultaneously, awareness programs and CPR training are improving public readiness, reducing the time-to-shock window and enhancing survival outcomes.<\/p>\n

3. Technological Innovation<\/strong> Modern defibrillators are evolving beyond basic shock delivery. Features such as wireless remote monitoring<\/strong>, AI-powered arrhythmia detection<\/strong>, Bluetooth connectivity<\/strong>, and MRI compatibility<\/strong> are setting new standards. Devices like Medtronic’s Cobalt XT and Boston Scientific’s RESONATE are leading this transformation, offering precision care and patient-centric innovation.<\/p>\n

Why Are Implantable Cardioverter Defibrillators (ICDs) Dominating the Market?<\/strong><\/p>\n

ICDs account for the largest share<\/strong> of the defibrillator market due to their continuous monitoring and automatic therapeutic intervention capabilities. Their ability to detect and treat life-threatening ventricular arrhythmias—without external input—makes them vital for high-risk patients.<\/p>\n

Advancements in ICDs also include:<\/p>\n